DAVID C BUPP Insider Trading $NAVB NAVIDEA BIOPHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID C BUPP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID C BUPP. DAVID C BUPP is CEO and President in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and Director in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB).
DAVID C BUPP in NAVIDEA BIOPHARMACEUTICALS, INC.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of DAVID C BUPP: Director, CEO and President
Holdings: 2,750,328 shares
Current Value: $1,430,171
Latest Transaction: Dec 20 2011
$NAVB Market Capitalization: $77.59M
$NAVB Previous Close: $0.52
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID C BUPP in NAVIDEA BIOPHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Sell | S | 2.54 | 7,814 | 19,848 | 2,750,328 | 2.8 M to 2.8 M (-0.28 %) |
| Dec 20 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Sell | S | 2.45 | 42,186 | 103,356 | 2,758,142 | 2.8 M to 2.8 M (-1.51 %) |
| Dec 20 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Grant | A | 0.00 | 300,000 | 0 | 2,900,328 | 2.6 M to 2.9 M (+11.54 %) |
| Nov 22 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Sell | S | 2.19 | 10,000 | 21,900 | 2,500,328 | 2.5 M to 2.5 M (-0.40 %) |
| Nov 22 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Sell | S | 2.25 | 6,100 | 13,725 | 2,510,328 | 2.5 M to 2.5 M (-0.24 %) |
| Nov 22 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Sell | S | 2.27 | 10,000 | 22,700 | 2,516,428 | 2.5 M to 2.5 M (-0.40 %) |
| Nov 21 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Sell | S | 2.28 | 23,900 | 54,492 | 2,526,428 | 2.6 M to 2.5 M (-0.94 %) |
| Oct 19 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Sell | S | 2.89 | 50,000 | 144,500 | 2,550,328 | 2.6 M to 2.6 M (-1.92 %) |
| Oct 19 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Gift | G | 0.00 | 13,000 | 0 | 2,600,328 | 2.6 M to 2.6 M (-0.50 %) |
| Jun 07 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Sell | S | 4.52 | 234,000 | 1,057,680 | 2,613,328 | 2.8 M to 2.6 M (-8.22 %) |
| Jun 07 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Grant | A | 0.00 | 300,000 | 0 | 2,543,328 | 2.2 M to 2.5 M (+13.37 %) |
| Jun 03 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Sell | S | 4.74 | 233,000 | 1,104,420 | 2,547,328 | 2.8 M to 2.5 M (-8.38 %) |
| Jun 03 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Sell | S | 5.00 | 233,000 | 1,165,000 | 2,780,328 | 3 M to 2.8 M (-7.73 %) |
| May 31 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Option Exercise | X | 0.31 | 20,000 | 6,200 | 0 | |
| May 31 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Option Exercise | X | 0.32 | 450,000 | 144,000 | 0 | |
| May 31 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Option Exercise | X | 0.31 | 320,000 | 99,200 | 0 | |
| May 31 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Buy | X | 0.00 | 20,000 | 0 | 213,746 | 193.7 K to 213.7 K (+10.32 %) |
| May 31 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Buy | X | 0.31 | 320,000 | 99,200 | 3,013,328 | 2.7 M to 3 M (+11.88 %) |
| May 31 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Buy | X | 0.32 | 450,000 | 144,000 | 2,693,328 | 2.2 M to 2.7 M (+20.06 %) |
| May 31 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | Director | Grant | A | 0.00 | 400,000 | 0 | 2,243,328 | 1.8 M to 2.2 M (+21.70 %) |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.26 | 200,000 | 52,000 | 0 | |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.27 | 300,000 | 81,000 | 0 | |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.39 | 200,000 | 78,000 | 0 | |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.49 | 150,000 | 73,500 | 0 | |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.13 | 70,000 | 9,100 | 0 | |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.14 | 100,000 | 14,000 | 0 | |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.30 | 125,000 | 37,500 | 0 | |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.42 | 180,000 | 75,600 | 0 | |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.36 | 200,000 | 72,000 | 0 | |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | C | 0.31 | 1,613,000 | 500,030 | 1,613,000 | |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | C | 0.31 | 3,225,806 | 1,000,000 | 0 | |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Payment of Exercise | F | 0.32 | 637,321 | 203,943 | 1,843,328 | 2.5 M to 1.8 M (-25.69 %) |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.13 | 70,000 | 9,100 | 2,480,649 | 2.4 M to 2.5 M (+2.90 %) |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.14 | 100,000 | 14,000 | 2,410,649 | 2.3 M to 2.4 M (+4.33 %) |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.30 | 125,000 | 37,500 | 2,310,649 | 2.2 M to 2.3 M (+5.72 %) |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.49 | 150,000 | 73,500 | 2,185,649 | 2 M to 2.2 M (+7.37 %) |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.42 | 180,000 | 75,600 | 2,035,649 | 1.9 M to 2 M (+9.70 %) |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.26 | 200,000 | 52,000 | 1,855,649 | 1.7 M to 1.9 M (+12.08 %) |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.36 | 200,000 | 72,000 | 1,655,649 | 1.5 M to 1.7 M (+13.74 %) |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.39 | 200,000 | 78,000 | 1,455,649 | 1.3 M to 1.5 M (+15.93 %) |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.27 | 300,000 | 81,000 | 1,255,649 | 955.6 K to 1.3 M (+31.39 %) |
| Apr 15 2011 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Sell | W | 0.00 | 40,000 | 0 | 940,649 | 980.6 K to 940.6 K (-4.08 %) |
| Nov 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.77 | 5,000 | 8,850 | 995,649 | 990.6 K to 995.6 K (+0.50 %) |
| Nov 16 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.76 | 10,000 | 17,600 | 990,649 | 980.6 K to 990.6 K (+1.02 %) |
| Jun 21 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.41 | 90,000 | 36,900 | 0 | |
| Jun 21 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 30,000 | 0 | 980,649 | 1 M to 980.6 K (-2.97 %) |
| Jun 21 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.41 | 90,000 | 36,900 | 1,010,649 | 920.6 K to 1 M (+9.78 %) |
| May 04 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.82 | 6,080 | 11,066 | 920,649 | 914.6 K to 920.6 K (+0.66 %) |
| May 04 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.81 | 7,400 | 13,394 | 914,569 | 907.2 K to 914.6 K (+0.82 %) |
| May 04 2010 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.80 | 16,520 | 29,736 | 907,169 | 890.6 K to 907.2 K (+1.85 %) |
| Dec 18 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.50 | 45,000 | 22,500 | 0 | |
| Dec 18 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Payment of Exercise | F | 1.17 | 27,851 | 32,586 | 890,649 | 918.5 K to 890.6 K (-3.03 %) |
| Dec 18 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.50 | 45,000 | 22,500 | 918,500 | 873.5 K to 918.5 K (+5.15 %) |
| Nov 24 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.04 | 10,000 | 10,400 | 873,500 | 863.5 K to 873.5 K (+1.16 %) |
| Nov 24 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.05 | 500 | 525 | 863,500 | 863 K to 863.5 K (+0.06 %) |
| Nov 24 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.07 | 4,000 | 4,280 | 863,000 | 859 K to 863 K (+0.47 %) |
| Nov 24 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.04 | 5,500 | 5,720 | 859,000 | 853.5 K to 859 K (+0.64 %) |
| Nov 24 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 1.06 | 10,000 | 10,600 | 853,500 | 843.5 K to 853.5 K (+1.19 %) |
| Jun 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.50 | 45,000 | 22,500 | 135,000 | |
| Jun 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.30 | 25,000 | 7,500 | 125,000 | |
| Jun 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 10,000 | 0 | 193,746 | 183.7 K to 193.7 K (+5.44 %) |
| Jun 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 40,000 | 0 | 843,500 | 883.5 K to 843.5 K (-4.53 %) |
| Jun 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 10,000 | 0 | 883,500 | 893.5 K to 883.5 K (-1.12 %) |
| Jun 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.30 | 25,000 | 7,500 | 893,500 | 868.5 K to 893.5 K (+2.88 %) |
| Jun 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.50 | 45,000 | 22,500 | 868,500 | 823.5 K to 868.5 K (+5.46 %) |
| Mar 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | X | 0.50 | 50,000 | 25,000 | 0 | |
| Mar 10 2009 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | X | 0.50 | 50,000 | 25,000 | 823,500 | 773.5 K to 823.5 K (+6.46 %) |
| Aug 21 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.62 | 3,095 | 1,919 | 773,500 | 770.4 K to 773.5 K (+0.40 %) |
| Aug 21 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.64 | 8,200 | 5,248 | 770,405 | 762.2 K to 770.4 K (+1.08 %) |
| Aug 21 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.65 | 8,705 | 5,658 | 762,205 | 753.5 K to 762.2 K (+1.16 %) |
| May 30 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 6,765 | 0 | 183,746 | 190.5 K to 183.7 K (-3.55 %) |
| Mar 28 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | M | 0.13 | 375,000 | 48,750 | 0 | |
| Mar 28 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 15,000 | 0 | 190,511 | 175.5 K to 190.5 K (+8.55 %) |
| Mar 28 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 60,000 | 0 | 753,500 | 813.5 K to 753.5 K (-7.38 %) |
| Mar 28 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | M | 0.13 | 375,000 | 48,750 | 813,500 | 438.5 K to 813.5 K (+85.52 %) |
Page: 1